Vitamin B12 deficiency can absolutely have a genetic component, though for most people it results from diet, absorption problems, or autoimmune processes rather than a single inherited gene. The full picture is layered: rare mutations in specific genes cause severe B12 deficiency from birth, common genetic variants subtly shift your circulating B12 levels up or down, and your immune-system genes influence whether you develop pernicious anemia. Getting B12 from food into your cells requires more than 15 different gene products working in sequence, and a problem at any step can lower what your body actually uses.
How Genes Move B12 From Food to Cells
Before looking at what goes wrong, it helps to know how many handoffs B12 needs just to get where it is going. After you eat B12-containing food, your stomach releases intrinsic factor, a protein that binds B12 and escorts it to a receptor in the small intestine. Once absorbed, B12 hitches a ride on a transport protein called transcobalamin II to reach your bloodstream and eventually your cells. Inside cells, it undergoes further chemical modifications to become the active forms your enzymes need.
Researchers have identified more than 15 gene products involved in this pathway, and some of those genes are dedicated exclusively to B12 transport while others serve additional roles in the body.
1PubMed. Vitamin B12 transport from food to the body’s cells–a sophisticated, multistep pathway That dual-purpose nature is part of why genetic B12 disorders vary so much in their symptoms: a mutation in a gene that only handles B12 looks different from one in a gene with broader responsibilities. The intracellular processing itself is equally complex, requiring modifications that shuffle B12 through different compartments before it can work as a cofactor.
2PubMed Central. Genetic disorders of vitamin B₁₂ metabolism: eight complementation groups–eight genes
Rare Inherited Disorders That Cause Severe Deficiency
A handful of rare genetic conditions can cause dangerous B12 deficiency starting in infancy or childhood. These are recessive, meaning a child needs to inherit a faulty copy of the gene from each parent. They are uncommon individually, but collectively they account for the most dramatic genetic causes of low B12.
Imerslund-Gräsbeck syndrome is one of the best-known examples. It causes B12 malabsorption and usually shows up with vague symptoms of deficiency along with protein in the urine. Without treatment, children with this condition can develop severe neurological problems.
3PubMed Central. Imerslund-Gräsbeck syndrome: a comprehensive review of reported cases Hereditary intrinsic factor deficiency is another culprit, caused by mutations in the gene that produces gastric intrinsic factor, the protein your stomach makes to bind B12 for absorption. Without functional intrinsic factor, dietary B12 simply passes through the gut unabsorbed.
4PubMed Central. Hereditary juvenile cobalamin deficiency caused by mutations in the intrinsic factor gene This condition has been identified in multiple families through both nonsense and missense mutations in the GIF gene, and it has been characterized in specific populations including Old Order Mennonite communities in Ontario.
5PubMed Central. Biochemical and Hematologic Manifestations of Gastric Intrinsic Factor (GIF) Deficiency: A Treatable Cause of B12 Deficiency in the Old Order Mennonite Population of Southwestern Ontario
Transcobalamin II deficiency takes the problem one step further down the chain. Even if B12 gets absorbed normally, it cannot reach the cells that need it because the transport protein in the blood is missing or nonfunctional. This is another recessive condition, and it depletes intracellular B12, impairing the enzymes that depend on it.
6PubMed. Transcobalamin II deficiency at birth The good news with all of these conditions is that once identified, they respond to B12 treatment, usually through injections that bypass whatever absorption step is broken.
Inborn Errors of Intracellular B12 Processing
Even after B12 enters your cells, genetic defects can prevent it from being converted into its active forms. The most common of these inborn errors is known as cblC disease, caused by mutations in the MMACHC gene. This condition blocks the synthesis of both adenosylcobalamin and methylcobalamin, the two forms cells actually use as enzyme cofactors.
7PubMed Central. Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management The result is a buildup of methylmalonic acid and homocysteine in the blood, both of which are toxic at high levels.
CblC disease is the most frequent inborn error of B12 metabolism overall, and it has been studied across populations including southern European cohorts in Italy and Portugal.
8PubMed. Spectrum of MMACHC mutations in Italian and Portuguese patients with combined methylmalonic aciduria and homocystinuria, cblC type It can present early in infancy with feeding difficulties, developmental delay, and seizures, but there is also a late-onset form that may not appear until adulthood. In adults with late-onset cblC disease, researchers have shown that high-dose hydroxocobalamin injections (initially daily, later spaced to weekly) combined with betaine and folic acid can achieve lasting biochemical correction and meaningful improvement in neurological and psychiatric symptoms.
9PubMed Central. High-dose hydroxocobalamin achieves biochemical correction and improvement of neuropsychiatric deficits in adults with late onset cobalamin C deficiency That finding underscores why recognizing genetic B12 disorders in adults matters: treatment works, but only if clinicians think to check for it.
Common Genetic Variants That Shift Your B12 Levels
The rare conditions above affect a small number of people. Far more widespread are common genetic variants, carried by large portions of the population, that nudge B12 levels modestly in one direction or another. These variants do not cause outright deficiency on their own, but they can push someone closer to the threshold, especially if diet or other factors are also working against them.
The most well-studied variant is in the FUT2 gene. FUT2 determines whether you are a “secretor,” meaning your blood-group antigens show up in saliva and other body fluids. A genome-wide scan in the Nurses’ Health Study found a strong association between a common FUT2 variant and plasma B12 levels, with women carrying two copies of one allele having higher circulating B12.
10PubMed Central. Common variants of FUT2 are associated with plasma vitamin B12 levels Follow-up work confirmed that this effect operates specifically through haptocorrin, one of the two B12-binding proteins in blood. B12 bound to haptocorrin was strongly influenced by FUT2 status, while B12 bound to transcobalamin, the protein that actually delivers B12 to cells, was not.
11PubMed Central. The FUT2 secretor variant p.Trp154Ter influences serum vitamin B12 concentration via holo-haptocorrin, but not holo-transcobalamin, and is associated with haptocorrin glycosylation In practical terms, your FUT2 genotype may shift the number on a standard blood test without necessarily changing how much B12 your cells are actually getting.
This FUT2 effect has been replicated across populations, including in an Indian cohort where the combination of a particular FUT2 genotype and a vegetarian diet was associated with significantly lower B12 levels.
12PubMed. Common variant in FUT2 gene is associated with levels of vitamin B(12) in Indian population That interaction between genes and diet is a theme that comes up repeatedly: genetic background may not cause deficiency by itself, but it can magnify the impact of a low-B12 diet.
Another common variant worth knowing about sits in the TCN2 gene, which encodes transcobalamin, the main delivery protein for B12 to your cells. A meta-analysis of genetic association studies found that one genotype at this site was linked to lower levels of holotranscobalamin, the active, B12-loaded form of the protein, and to higher homocysteine in people of European descent.
13PubMed Central. Association of TCN2 rs1801198 c.776G>C polymorphism with markers of one-carbon metabolism and related diseases: a systematic review and meta-analysis of genetic association studies A study in older Hispanic adults confirmed that while total B12 did not differ by TCN2 genotype, the ratio of active holotranscobalamin to total B12 was significantly lower in one genotype group.
14PubMed Central. Transcobalamin C776G Genotype Modifies the Association between Vitamin B12 and Homocysteine in Older Hispanics Again, the standard blood test for total B12 might look fine while the biologically active fraction is actually running low.
When a Low Test Result Is Actually Harmless
Not every genetically driven low B12 reading on a blood test means you are deficient. Transcobalamin I (also called haptocorrin) normally carries over 70% of the B12 circulating in your blood, but it does not deliver B12 to your cells. People with inherited transcobalamin I deficiency have very low total serum B12 on standard tests, yet their cellular B12 status is perfectly normal.
15Blood. Mutations of TCN1 Cause Transcobalamin I Deficiency with Low Serum Cobalamin Levels That Are Indistinguishable From Cobalamin Deficiency Without awareness of this condition, a doctor might start unnecessary treatment or trigger unwarranted anxiety. This is one reason why additional markers like methylmalonic acid (MMA) and homocysteine, which reflect how well B12 is actually functioning inside cells, can be more informative than the total serum level alone.
16International Journal of Innovative Technologies in Social Science. NORMAL SERUM VITAMIN B12 LEVELS IN SYMPTOMATIC PATIENTS: DIAGNOSTIC VALUE OF METHYLMALONIC ACID AND HOMOCYSTEINE IN FUNCTIONAL DEFICIENCY
The flip side is also true: you can have a normal-looking serum B12 while your cells are functionally starved, particularly if you carry variants in TCN2 that reduce the active delivery fraction. The message here is that genetics can mess with the test just as much as it can mess with actual B12 status, and the two are not always the same thing.
Pernicious Anemia and Immune-System Genes
Pernicious anemia, the autoimmune destruction of the stomach cells that produce intrinsic factor, is the single most common cause of severe B12 deficiency in older adults. It is not a straightforward inherited disease, but genetic susceptibility plays a clear role. A genome-wide association study identified five risk loci for pernicious anemia, including one in the HLA region on chromosome 6, the stretch of DNA most closely associated with immune function. The specific HLA haplotype involved, HLA-DR15, is also a known risk factor for multiple sclerosis, reflecting the shared immune architecture underlying many autoimmune conditions.
17Nature Communications. Genome-wide association study identifies five risk loci for pernicious anemia
Family studies in the Swedish population have also shown that pernicious anemia clusters with other autoimmune diseases, consistent with shared HLA haplotypes raising susceptibility across multiple conditions.
18PubMed Central. Familial Risks between Pernicious Anemia and Other Autoimmune Diseases in the Population of Sweden If you have a first-degree relative with pernicious anemia, or a family history of autoimmune thyroid disease, type 1 diabetes, or vitiligo, your own risk is elevated. That does not guarantee you will develop it, but it is worth being aware of, especially if you start experiencing fatigue, numbness, or brain fog.
How Genes and Environment Team Up
For most people, B12 deficiency is not purely genetic or purely environmental; it is an interaction between the two. The FUT2-plus-vegetarian-diet finding from Indian populations is one example. A broader one involves the MTHFR gene, which encodes an enzyme in the folate cycle that works closely with B12. People with certain MTHFR variants do not become B12-deficient because of the variant itself, but when they are B12-deficient, their symptoms may be worse. A study of B12-deficient patients found that those carrying the MTHFR C677T variant had significantly lower hemoglobin and platelet counts than those without the variant, and carriers of the A1298C variant also had lower hemoglobin.
19PubMed Central. MTHFR polymorphisms and vitamin B12 deficiency: correlation between mthfr polymorphisms and clinical and laboratory findings The MTHFR variant does not cause B12 deficiency, but it amplifies the damage when deficiency is present.
Diet is arguably the largest environmental factor. Vitamin B12 is not made by plants, and unfortified plant-based foods are not a reliable source. Vegetarians and vegans have high rates of deficiency, and the risk is especially pronounced in pregnant women or women of childbearing age who have shifted to plant-based diets.
20PubMed Central. The importance of vitamin B12 for individuals choosing plant-based diets For someone who already carries a FUT2 variant that lowers circulating B12, or a TCN2 variant that reduces the active delivery fraction, a plant-based diet without supplementation could push them from “genetically lower but adequate” into “functionally deficient.”
The Metformin Connection and Pharmacogenomics
One of the more striking gene-environment interactions involves metformin, the widely prescribed diabetes medication. Metformin is known to lower B12 levels in some users, but the extent of that effect varies dramatically from person to person, and a recent study identified a genetic reason why. A variant in the CUBN gene, which encodes cubilin (part of the receptor complex that absorbs B12 in the intestine), was strongly associated with metformin-induced B12 deficiency. Among people not taking metformin, the CUBN genotype made almost no difference: B12 deficiency rates were around 1% regardless. But among metformin users, the rates diverged sharply. Those with two copies of the risk allele had a deficiency rate roughly double that of people with no copies. Looking at it over time, 10% of people with the high-risk genotype became B12-deficient within about 11 years of starting metformin, while the same threshold took roughly 21 years for those with the low-risk genotype.
21PubMed Central. Identification of a genetic risk factor for metformin-induced vitamin B(12) deficiency
This is a textbook case of a gene-drug interaction: the gene variant does essentially nothing on its own, but the combination of the variant and the medication creates a meaningful clinical problem. As genetic testing becomes cheaper, this kind of finding could eventually guide more targeted B12 monitoring for people starting metformin, rather than the current one-size-fits-all approach.
Effects That Cross Generations
Genetics can influence B12 status in another, less obvious way: through epigenetic changes passed between generations. B12 and folate are both essential for DNA methylation, a chemical process that helps regulate which genes are active and which are silenced. When researchers manipulated maternal B12 and folate levels in animal models, they found that deficiency of both nutrients decreased global DNA methylation in maternal tissues while increasing it in fetal tissues. The combination of B12 deficiency and folate deficiency produced particularly large shifts in methylation patterns in offspring of both sexes.
22Nature / Scientific Reports. Effect of imbalance in folate and vitamin B12 in maternal/parental diet on global methylation and regulatory miRNAs
These findings are from animal models, so extrapolating directly to humans requires caution. But they suggest that a mother’s B12 status during pregnancy may influence her child’s gene regulation in ways that persist beyond birth. This adds another dimension to the genetic story: you do not need to inherit a mutated gene to be affected by your parents’ B12 status. The emerging picture is that B12 deficiency during critical developmental windows could leave an epigenetic fingerprint on the next generation, independent of the DNA sequence itself.
What Better Testing Could Look Like
Standard B12 blood tests measure total serum cobalamin, which includes B12 bound to both haptocorrin and transcobalamin. As discussed earlier, haptocorrin-bound B12 is not biologically active, and genetic variants in FUT2 and TCN1 can inflate or deflate this fraction without changing what your cells receive. Total serum B12 has limited sensitivity for catching early or functional deficiency.
16International Journal of Innovative Technologies in Social Science. NORMAL SERUM VITAMIN B12 LEVELS IN SYMPTOMATIC PATIENTS: DIAGNOSTIC VALUE OF METHYLMALONIC ACID AND HOMOCYSTEINE IN FUNCTIONAL DEFICIENCY MMA is more specific to B12-related metabolic problems, though it can be thrown off by kidney function and age.
If you have a family history of B12 deficiency, autoimmune conditions, or unexplained neurological symptoms with normal-looking B12 levels, asking for MMA and homocysteine testing can be worthwhile. Holotranscobalamin, which measures only the biologically active fraction, is available in some labs and may give a clearer picture for people whose genetics are skewing the total B12 number. None of these tests are routinely ordered for everyone, but they exist and can make a real difference when the standard test is misleading.
Genetic Testing for B12-Related Conditions
For the rare monogenic disorders, genetic testing can provide a definitive diagnosis. If a child presents with megaloblastic anemia in infancy and does not respond to standard interventions, testing for mutations in the GIF, CUBN, AMN, or TCN2 genes can identify the specific defect and guide lifelong treatment, typically with B12 injections. For the intracellular processing disorders like cblC disease, MMACHC gene testing confirms the diagnosis. Some newborn screening programs have explored including markers for cblC disease, since early treatment can prevent or reduce neurological damage.
For common variants like FUT2 and TCN2 polymorphisms, genetic testing is available through commercial platforms but is generally not necessary for clinical decision-making. Knowing you carry a FUT2 non-secretor variant might explain a slightly lower B12 reading, but it would not change the recommendation to eat B12-rich foods or supplement if your diet is low in animal products. Where genetic testing may have more practical value is in pharmacogenomics: identifying CUBN variants before starting metformin, for example, could flag patients who need more aggressive B12 monitoring. That application is not yet standard practice, but the data supporting it is accumulating.
The people for whom a genetic lens matters most are those with unexplained, persistent low B12 despite adequate diet and no obvious absorption problems, and families where B12 deficiency keeps appearing across generations without an obvious dietary explanation. In those situations, thinking beyond diet and lifestyle to consider hereditary factors is not just academic. It can change the diagnosis, the treatment plan, and what the rest of the family should be watching for.